Breaking News

AAIPharma Services and CML Appoints CEO

July 8, 2014

Lonza veteran brings extensive experience

Stephan Kutzer, Ph.D. has been appointed chief executive officer of AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. (CML), effective August 1st.
 
Dr. Kutzer joins the company from Lonza, Inc., where he served as chief operating officer of Lonza, Inc., part of the Lonza Group. Since 2003, he has also served as chief operating officer and/or president of several Lonza divisions, including Pharma Biotech, Custom Manufacturing, Biopharmaceuticals and Performance Chemicals. Previously, he served as site director and vice president of operations of Lonza’s Bayport, TX facilities, and was director of process improvement at Lonza Guangzhou Ltd. in China. 
 
“Stephan brings valuable leadership experience with over 18 years’ in the pharmaceutical industry. His diverse background in operations, technical services, API development and manufacturing positions him well to take our company to the next level,” said Susan Nestegard, acting chief executive officer.  “He will continue our focus on best in class safety, quality, and exceeding customer expectations to achieve our vision of being the Contract Manufacturing and Development Organization (CDMO) of first choice in the pharmaceutical sector.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks